Home > Blog > Advanced Therapies & Technology Travelling overseas for surgery can feel complicated even when someone is coming with you. If you are going alone, the questions become more immediate: who will help during admission, who can speak with hospital staff, and who will be there when you leave the ward? You may be perfectly independent before the procedure. The harder part is planning for the hours or days when you could be tired, uncomfortable or unable to deal with t

Home > Blog > Advanced Therapies & Technology Paying a Chinese public hospital can become stressful when the admission date is close and basic questions are still unresolved. A Visa card in your wallet and Alipay on your phone may feel like enough preparation. Neither tells you whether the hospital can take the full deposit at check-in—or what you will do if the transaction is declined. Before travelling, confirm the expected amount, payment deadline, authorized payee, accept

Home > Blog > Advanced Therapies & Technology If you are considering another operation after a previous procedure, a remote second opinion can feel like the point where uncertainty should finally end. Sometimes it brings welcome clarity. A specialist may be able to review your surgical history, examine your imaging and identify the next sensible step. In other cases, the most responsible answer is that a final decision cannot yet be made without new imaging, a physical examin

Home > Blog > Advanced Therapies & Technology An MRI performed overseas can give a specialist in China a useful first look at a surgical case. It may document the anatomy and recent changes, and help the clinician decide what information is still needed. But a scan that is clear enough for an initial review may still be unsuitable for final surgical planning. Where the scan was performed is not the deciding issue. For someone arranging an overseas MRI for surgery in China, tw

Home > Blog > Advanced Therapies & Technology Last updated: September 2026 A surgical file can be complete when it is first submitted and out of date a few weeks later. For an international patient seeking surgical review in China, a new procedure, medication change, different symptoms, further imaging or a revised question can all affect what the receiving specialist needs to see. The older records are not necessarily wrong. They simply may no longer tell the whole story. To

Home > Blog > Advanced Therapies & Technology When you are planning international travel around possible surgery, the word “confirmed” can sound firmer than it really is. A China hospital admission notice is a meaningful step. However, it does not necessarily mean that a hospital bed, reporting time or final surgery date has been confirmed. Those details may arrive in separate messages, sometimes at different stages of the hospital process. Before paying for non-refundable fl

Home > Blog > Advanced Therapies & Technology Written by: MedBridgeNZ Administrative review: MedBridgeNZ Limited Evidence note: This guide combines lessons from one anonymised coordination pathway with current public sources. When you are considering surgery abroad, the first question is often, "Which hospital?" In practice, another question comes first: what has actually been confirmed? The pathway to surgery in China for international patients rarely turns on a single email

Home > Blog > Advanced Therapies & Technology Written by the MedBridgeNZ Patient Care Team | Updated September 2026 Key Takeaways Ask for the exact trial registration number. A hospital name, treatment label or brochure is not enough to identify a study. Check whether the sponsor, cell product, investigator, hospital campus and recruitment status match the public record. A registry entry establishes traceability. Current recruitment, international access and individual eligib

Home > Blog > Advanced Therapies & Technology A search for an experimental Parkinson’s treatment can uncover a more basic question: is the diagnosis definitely Parkinson’s disease, or does the medical record describe parkinsonism without confirming its cause? This is more than a difference in terminology. Parkinsonism describes a pattern of movement signs. Parkinson’s disease is one possible cause—and the cause matters before an invasive treatment is considered. Atypical neur

Home > Blog > Advanced Therapies & Technology For a family exploring medical care overseas, the first question is often about treatment: Is a particular therapy available? Is a clinical trial accepting international patients? Would travelling to China open up another option? Those questions matter, but a specialist usually needs to answer a more basic one first: is there enough reliable information to review the case properly? A remote Parkinson’s second opinion in China can

Home > Blog > Advanced Therapies & Technology Families often reach this question after finding a Parkinson’s study online and wondering whether it is worth contacting the hospital—or even planning a trip to China. The possibility may feel encouraging, but a public listing rarely explains how the study handles enquiries from people who live overseas. Some international patients may be assessed for Parkinson’s clinical trials in China. Acceptance, however, depends on the protoc

Home > Blog > Advanced Therapies & Technology By MedBridgeNZ | Last updated: 30 August 2026 | Evidence reviewed: 30 August 2026 For families reading a trial listing, the published age range can look like a clear doorway: “My relative has Parkinson’s disease and falls within that range—does this mean they qualify?” Unfortunately, no public listing can answer that question on its own. Age is only the most visible part of Parkinson’s stem cell trial eligibility in China. Before

Home > Blog > Advanced Therapies & Technology A remote oncology consultation can provide another specialist’s perspective without requiring the patient to travel immediately. Its usefulness, however, depends partly on whether the specialist receives relevant medical records and clearly prioritised questions. The most useful remote oncology consultation questions go beyond asking, “What treatment do you recommend?” They should clarify what the submitted records show, what rema

Home > Blog > Advanced Therapies & Technology In an oncology record, the difference between PD-1 and PD-L1 may appear to be only two characters. Clinically, however, the terms do not describe the same protein, the same drug target, or the same type of medical information. PD-1 is an immune checkpoint receptor found on immune cells, including T cells. PD-L1 is one of the proteins that can bind to PD-1. Some medicines block PD-1, while others block PD-L1. The distinction become

Home > Blog > Advanced Therapies & Technology Finding a gene alteration in a cancer report can appear to offer a clear next step: identify the mutation, locate a medicine that targets it, and begin treatment. In practice, the relationship between a cancer mutation and targeted therapy is more complex. A tumor genomic report may identify mutations, deletions, amplifications, fusions, and other biomarkers. However, detecting an alteration does not automatically prove that it dr

Home > Blog > Advanced Therapies & Technology When a cancer diagnosis is complex, treatment options appear limited, or the disease has progressed despite therapy, patients and families may begin exploring specialists and hospitals in other countries. China may be considered because its major oncology centers include disease-specific specialists and treatment pathways that may differ from those previously discussed with the patient. But finding another possible treatment appro

Home > Blog > Advanced Therapies & Technology Key Takeaways The Chinese healthcare system provides structured pathways to access innovative medicines through National Medical Products Administration (NMPA) approvals and special medical zones. While 3,159 medicines are included in the national reimbursement catalog, institutional availability depends on specific hospital formularies and centralized procurement cycles. For some medicines and indications, public medicine pri

Home > Blog > Advanced Therapies & Technology Key Takeaways Amimestrocel (trade name: 睿铂生; transliterated as Ruibosheng) has received conditional approval from the Chinese National Medical Products Administration (NMPA) for a highly specific hematological indication. It is restricted to patients aged 14 and older with steroid-refractory acute graft-versus-host disease (SR-aGVHD) predominantly involving the gastrointestinal tract. The publicly reported medicine price in Ch

Home > Blog > Advanced Therapies & Technology Key Takeaways China has approved lecanemab and donanemab for selected patients with early symptomatic Alzheimer’s disease. In practice, these treatments are generally delivered through hospitals with specialist neurology, infusion, biomarker-testing, and MRI-monitoring capabilities. Important: These medicines do not cure Alzheimer’s disease and are intended only for selected patients in the early symptomatic stage with confirmed

Home > Blog > Advanced Therapies & Technology Key Takeaway Targeted Dose Distribution: Particle therapy leverages the Bragg-peak effect to create a sharp distal fall-off, which may reduce radiation exposure to selected nearby healthy tissues compared to conventional X-ray therapy. Advanced Clinical Infrastructure: China has developed multiple specialized proton and carbon-ion treatment centers in several major cities, providing clinical access to modalities evaluated for spec